0,926  0,005  Antiinflammatory
0,834  0,013  Apoptosis agonist
0,807  0,007  CYP2C9 substrate
0,786  0,005  Antiepileptic
0,766  0,005  Nitric oxide antagonist
0,764  0,005  Sensitization
0,752  0,005  CYP2C19 substrate
0,757  0,012  Antineoplastic (lung cancer)
0,740  0,015  Antineoplastic (breast cancer)
0,729  0,005  AR expression inhibitor
0,719  0,015  Teratogen
0,707  0,014  Embryotoxic
0,710  0,019  Transcription factor NF kappa B inhibitor
0,693  0,005  Immunosuppressant
0,689  0,004  Hair growth stimulant
0,690  0,007  Cardiovascular analeptic
0,692  0,009  Antineoplastic (ovarian cancer)
0,683  0,004  UGT1A4 substrate
0,678  0,004  Antineoplastic (endocrine cancer)
0,633  0,008  Antineoplastic (pancreatic cancer)
0,618  0,010  NOS2 expression inhibitor
0,615  0,015  Chemoprotective
0,607  0,014  Bone diseases treatment
0,612  0,023  TNF expression inhibitor
0,586  0,014  Antineoplastic (melanoma)
0,582  0,012  Antiosteoporotic
0,572  0,020  Respiratory analeptic
0,552  0,014  Apoptosis antagonist
0,566  0,029  Antileukemic
0,544  0,008  UGT1A1 substrate
0,551  0,017  Antineoplastic (cervical cancer)
0,533  0,004  Abortion inducer
0,532  0,004  Antiviral (Influenza A)
0,540  0,022  Antipruritic, allergic
0,518  0,003  UGT2B9 substrate
0,513  0,004  UGT2B7 substrate
0,524  0,017  Proliferative diseases treatment
0,505  0,011  Vascular (periferal) disease treatment
0,491  0,005  Antiviral (Influenza)
0,490  0,005  Antiacne
0,497  0,019  Chemopreventive
0,485  0,012  Sedative
0,493  0,024  Carcinogenic
0,471  0,004  Antifungal enhancer
0,505  0,040  CYP3A4 substrate
0,482  0,017  Antiparasitic
0,468  0,007  Prostate disorders treatment
0,465  0,005  Lipocortins synthesis antagonist
0,477  0,023  NOS3 expression inhibitor
0,449  0,004  T cell inhibitor
0,453  0,009  Prostatic (benign) hyperplasia treatment
0,480  0,039  Antineoplastic (colorectal cancer)
0,450  0,009  Carcinogenic, group 3
0,449  0,009  Contraceptive
0,476  0,036  Prostate cancer treatment
0,450  0,013  Antihelmintic
0,440  0,008  5 Hydroxytryptamine uptake stimulant
0,446  0,016  UDP-glucuronosyltransferase substrate
0,468  0,038  Antineoplastic (colon cancer)
0,457  0,027  Analeptic
0,446  0,021  UGT2B4 substrate
0,455  0,030  Hepatic disorders treatment
0,429  0,007  Antipruritic, non-allergic
0,431  0,016  Myocardial infarction treatment
0,445  0,033  Antifungal
0,476  0,070  Caspase 9 stimulant
0,397  0,004  Vanilloid agonist
0,392  0,004  Alcohol dehydrogenase substrate
0,393  0,010  Antialcoholic
0,413  0,035  ICAM1 expression inhibitor
0,438  0,061  Antibacterial
0,389  0,011  Interferon gamma antagonist
0,394  0,019  Sodium/bile acid cotransporter inhibitor
0,385  0,010  Pneumotoxic
0,384  0,017  Muscle relaxant
0,358  0,004  Choleretic
0,367  0,017  Hepatoprotectant
0,339  0,002  Ca(v)3.1 blocker
0,372  0,037  Calcium channel activator
0,374  0,049  Antihypercholesterolemic
0,330  0,007  Autism spectrum disorders treatment
0,356  0,034  Antidiabetic symptomatic
0,401  0,090  Cyclophilin D inhibitor
0,401  0,090  Antidiabetic
0,353  0,046  Antioxidant
0,338  0,036  Angiogenesis stimulant
0,327  0,028  Anesthetic general
0,320  0,024  Antihypotensive
0,331  0,035  DNA synthesis inhibitor
0,298  0,003  5-Alpha-reductase inhibitor
0,339  0,045  Cytotoxic
0,331  0,039  Antineoplastic (liver cancer)
0,313  0,022  Skin irritative effect
0,296  0,007  Androgen antagonist
0,308  0,020  Anesthetic
0,291  0,004  Posttraumatic stress disorder treatment
0,341  0,055  Spasmolytic
0,307  0,021  Melanin inhibitor
0,312  0,029  Antiviral (HIV)
0,338  0,063  CYP2D6 substrate
0,278  0,010  Expectorant
0,302  0,042  Psychostimulant
0,318  0,062  CTGF expression inhibitor
0,278  0,025  CYP2B6 inhibitor
0,273  0,022  UGT2B15 substrate
0,255  0,005  Arachidonic acid antagonist
0,324  0,077  Cholesterol antagonist
0,353  0,107  Analgesic
0,333  0,096  Antiobesity
0,246  0,010  Microtubule formation inhibitor
0,243  0,007  Aldehyde dehydrogenase substrate
0,249  0,013  Endometrios treatment
0,240  0,006  Postmenopausal disorders treatment
0,235  0,006  Actinic keratosis treatment
0,244  0,015  Antineoplastic antibiotic
0,260  0,033  Neurotrophic factor enhancer
0,265  0,039  VCAM1 expression inhibitor
0,251  0,032  Antiviral (Herpes)
0,229  0,010  Contraceptive female
0,251  0,032  Antiviral (Hepatitis)
0,298  0,080  Caspase 3 stimulant
0,276  0,062  Antiprotozoal (Leishmania)
0,245  0,031  Antineoplastic (carcinoma)
0,233  0,019  UGT2B10 substrate
0,216  0,013  Movement disorders treatment
0,211  0,011  Antineoplastic alkaloid
0,203  0,004  Anabolic
0,202  0,004  Aldosterone antagonist
0,230  0,032  Protein kinase stimulant
0,250  0,056  Antihypertriglyceridemic
0,205  0,010  Contraceptive male
0,208  0,014  Menstruation disorders treatment
0,205  0,011  Vanilloid 1 agonist
0,214  0,022  Neurotrophic factor
0,196  0,004  UGT2B11 substrate
0,309  0,118  Antiprotozoal
0,253  0,065  Antineoplastic (sarcoma)
0,218  0,033  Antiviral (Hepatitis C)
0,256  0,072  Antineoplastic (glioma)
0,189  0,005  Antiprotozoal activity enhancer
0,226  0,043  Eye irritation, high
0,216  0,033  Toxic, respiratory center
0,222  0,042  Diabetic nephropathy treatment
0,228  0,049  P-glycoprotein inhibitor
0,188  0,013  TRPA1 agonist
0,178  0,004  Glycine receptor antagonist
0,209  0,036  Interleukin 6 antagonist
0,186  0,021  Growth stimulant
0,178  0,018  GABA C receptor antagonist
0,169  0,011  SULT1E1 substrate
0,168  0,011  Aromatase inhibitor
0,187  0,031  Antiviral (Hepatitis B)
0,164  0,010  Estrogen agonist
0,233  0,080  Vasodilator
0,196  0,043  Antirickettsial
0,259  0,107  Antineoplastic (osteosarcoma)
0,288  0,137  CYP2C19 inhibitor
0,153  0,007  Androgen agonist
0,163  0,019  Ca2+-transporting ATPase inhibitor
0,174  0,031  Adenylate cyclase stimulant
0,174  0,034  Antieczematic
0,205  0,066  Mutagenic
0,159  0,020  Antispirochetal
0,234  0,100  Lipoprotein disorders treatment
0,142  0,008  Na+ K+ transporting ATPase inhibitor
0,149  0,016  Antiviral (SARS coronavirus)
0,149  0,016  Antiviral (Coronavirus)
0,196  0,063  Sigma receptor agonist
0,156  0,025  Antiviral (Influenza B)
0,147  0,016  Transcription factor NF kappa B stimulant
0,239  0,111  Hypoxia-inducible factor 1 alpha inhibitor
0,180  0,053  Diuretic
0,271  0,145  Atherosclerosis treatment
0,207  0,088  UGT1A6 substrate
0,143  0,026  Estrogen antagonist
0,142  0,026  Prolactin inhibitor
0,207  0,091  Potassium channel (Voltage-sensitive) blocker
0,252  0,137  Antiprotozoal (Plasmodium)
0,145  0,030  Sulfotransferase substrate
0,156  0,041  Cholesterol synthesis inhibitor
0,146  0,035  Mucolytic
0,156  0,046  Farnesoid X receptor antagonist
0,121  0,012  Narcotic antagonist
0,215  0,109  5 Hydroxytryptamine release stimulant
0,152  0,047  Antihyperlipoproteinemic
0,195  0,091  Antiparkinsonian, rigidity relieving
0,194  0,093  Antiulcerative
0,109  0,008  Progesterone antagonist
0,105  0,005  Postcoital contraceptive
0,139  0,041  SULT1A1 substrate
0,121  0,024  Inducible nitric-oxide synthase inhibitor
0,107  0,010  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,102  0,006  RNA-directed RNA polymerase stimulant
0,099  0,005  Lipocortins synthesis agonist
0,201  0,108  Tumour necrosis factor alpha release inhibitor
0,196  0,104  Cytostatic
0,102  0,010  Hypercalcemia treatment
0,106  0,015  Anticholelithogenic
0,240  0,149  GST A substrate
0,121  0,030  Estrogen receptor beta antagonist
0,130  0,041  AMP-activated protein kinase stimulant
0,195  0,106  Peptidyltransferase inhibitor
0,090  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,143  0,058  Cocaine dependence treatment
0,208  0,123  Antineurogenic pain
0,092  0,007  Anesthetic inhalation
0,097  0,012  Estrogen receptor beta agonist
0,203  0,118  Immunostimulant
0,093  0,009  Potassium channel Kv1.3 blocker
0,089  0,005  Glucocorticoid antagonist
0,113  0,029  Antibiotic
0,094  0,012  SULT2A1 substrate
0,191  0,113  RNA-directed DNA polymerase inhibitor
0,157  0,079  Antihelmintic (Nematodes)
0,132  0,054  Protein-tyrosine phosphatase 1B inhibitor
0,096  0,018  Antitreponemal
0,102  0,026  Estrogen receptor alpha antagonist
0,151  0,075  Acute respiratory distress syndrome (ARDS) treatment
0,211  0,139  CYP1A2 substrate
0,083  0,011  Estrogen receptor alpha agonist
0,177  0,105  Dependence treatment
0,106  0,036  Topoisomerase II alpha inhibitor
0,161  0,093  Succinate dehydrogenase inhibitor
0,197  0,132  UGT1A9 substrate
0,119  0,055  Carcinogenic, group 2B
0,091  0,028  Glycine receptor agonist
0,160  0,098  LDLR expression enhancer
0,068  0,007  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,137  0,076  Antiparkinsonian, tremor relieving
0,114  0,053  Antiprotozoal (Toxoplasma)
0,072  0,012  Pregnane X receptor antagonist
0,097  0,037  3C-Like protease (SARS coronavirus) inhibitor
0,146  0,086  UGT1A3 substrate
0,110  0,051  Antihypermotility
0,135  0,076  Antineoplastic (squamous cell carcinoma)
0,202  0,143  Antihypoxic
0,063  0,006  Kainate receptor agonist
0,138  0,082  Genotoxic
0,067  0,012  Cholesterol esterase inhibitor
0,060  0,005  Tubulin agonist
0,063  0,009  GABA uptake inhibitor
0,085  0,032  Vanilloid 4 agonist
0,101  0,049  ABCA1 expression enhancer
0,117  0,065  Shock treatment
0,199  0,148  Antipsoriatic
0,076  0,025  Antimycoplasmal
0,153  0,103  Sleep disorders treatment
0,214  0,164  GST M1-1 substrate
0,051  0,003  Hedgehog signaling activator
0,071  0,023  Protein 50S ribosomal subunit inhibitor
0,061  0,013  Retinoid X receptor agonist
0,061  0,014  Microtubule stabilization
0,098  0,053  Antiviral (Rhinovirus)
0,094  0,051  Ornithine decarboxylase inhibitor
0,133  0,092  Antifungal (Cryptococcus)
0,123  0,082  Skin whitener
0,104  0,064  Beta glucuronidase inhibitor
0,105  0,065  UGT2B1 substrate
0,185  0,148  Cardioprotectant
0,040  0,004  Vanilloid 2 agonist
0,138  0,102  Uterine stimulant
0,057  0,021  Estradiol 17 beta-dehydrogenase inhibitor
0,040  0,005  Glucocorticoid agonist
0,040  0,005  Progesterone agonist
0,120  0,086  Antihemorrhagic
0,087  0,053  Antiviral (Trachoma)
0,130  0,098  NOS3 expression enhancer
0,036  0,005  Corticosteroid-like
0,049  0,018  Hypogonadism treatment
0,091  0,061  Paget's disease treatment
0,038  0,008  5-Alpha-reductase 1 inhibitor
0,065  0,035  Heme oxygenase stimulant
0,107  0,078  Proteasome inhibitor
0,072  0,044  Premenstrual syndrome treatment
0,050  0,022  Parathyroid hormone antagonist
0,044  0,016  Antihyperaldosteronism
0,126  0,100  Acetylcholine M1 receptor antagonist
0,043  0,017  Glucose-6-phosphate dehydrogenase inhibitor
0,209  0,184  Stroke treatment
0,190  0,165  Gastrin inhibitor
0,052  0,028  Mineralocorticoid receptor antagonist
0,228  0,205  Antiparkinsonian
0,117  0,094  Antimutagenic
0,208  0,186  FMO1 substrate
0,114  0,091  Bone formation stimulant
0,030  0,007  Vitamin D receptor antagonist
0,030  0,009  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,199  0,178  Antithrombotic
0,031  0,010  Estrone sulfatase inhibitor
0,059  0,039  Calcium channel T-type blocker
0,154  0,135  Antiglaucomic
0,073  0,054  Cushing's syndrome treatment
0,126  0,110  Pregnane X receptor agonist
0,093  0,077  Topoisomerase I inhibitor
0,046  0,031  Adenylate cyclase 1 inhibitor
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,101  0,087  Alkylator
0,028  0,016  Retinoid X gamma receptor antagonist
0,019  0,007  Vitamin D receptor agonist
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,099  0,087  DNA polymerase I inhibitor
0,140  0,129  Phospholipase C inhibitor
0,021  0,011  Progesterone receptor B antagonist
0,097  0,087  Adenylate cyclase inhibitor
0,152  0,142  Free radical scavenger
0,018  0,010  Telomerase stimulant
0,199  0,192  Interleukin 2 agonist
0,119  0,112  Skeletal muscle relaxant
0,097  0,091  Electron transport complex I inhibitor
0,007  0,003  Transcortin receptor antagonist
0,146  0,142  Aldehyde oxidase inhibitor
0,020  0,017  Retinoid X beta receptor antagonist
0,078  0,076  Antineoplastic, alkylator
0,116  0,114  Antianemic
0,020  0,019  GRP78 expression inhibitor
0,070  0,069  Acetylcholine nicotinic antagonist
0,021  0,020  Retinoic acid gamma receptor agonist
0,036  0,035  Vanilloid 3 antagonist
0,020  0,020  Retinoid X gamma receptor agonist

